Volume 8, Issue 1 (2022)
IEM 2022, 8(1): 77-86 |
Back to browse issues page
Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Arfaatabar M, Shahbazi T, Ebrahimi T. Prevalence of Vancomycin and Gentamycin Resistance among Enterococci spp. in Iran during 2007-2019: A Systematic Review. IEM 2022; 8 (1) :77-86
URL: http://iem.modares.ac.ir/article-4-56253-en.html
URL: http://iem.modares.ac.ir/article-4-56253-en.html
1- Department of Medical Laboratory Science, Kashan Branch, Islamic Azad University, Kashan, Iran , m.arfaatabar@iaukashan.ac.ir
2- Department of Bacteriology, Faculty of Medical Sciences, Tarbiat Modares University, Tehran Iran,
3- Department of Medical Laboratory Science, Kashan Branch, Islamic Azad University, Kashan, Iran
2- Department of Bacteriology, Faculty of Medical Sciences, Tarbiat Modares University, Tehran Iran,
3- Department of Medical Laboratory Science, Kashan Branch, Islamic Azad University, Kashan, Iran
Abstract: (1500 Views)
Backgrounds: Enterococci are Gram-positive bacteria that colonize the intestine of warm-blooded animals and humans as normal flora. Enterococci cause a variety of community-acquired and nosocomial infections. The emergence of vancomycin and gentamicin resistant enterococci has made a major challenge in the treatment of enterococcal infections worldwide. Therefore, the present study was conducted to evaluate the prevalence of vancomycin and gentamycin resistance among Enterococcus spp in Iran during 2007-2019.
Materials & Methods: In this study, 26 studies were reviewed to collect data on the frequency of vancomycin and gentamicin resistant enterococci in Iran. To find studies published during January 2007 to January 2019, a search strategy was performed by searching different Iranian and international databases, including SID, Google Scholar, Scopus, Medline, Pub Med, and Web of Science.
Findings: The prevalence of vancomycin- and gentamicin-resistant enterococci was very high in Iran (41 and 44%, respectively). Accordingly, Enterococcus faecalis was more prevalent in clinical samples compared to E. faecium (75.49% vs. 24.05%). However, resistance to vancomycin was higher in E. faecium strains compared to E. faecalis.
Conclusion: Due to the increasing vancomycin and gentamicin resistance among Enterococcus species in Iran, it is necessary to design strategies that lead to the rational prescription of antibiotics and limit the spread of resistant enterococci.
Materials & Methods: In this study, 26 studies were reviewed to collect data on the frequency of vancomycin and gentamicin resistant enterococci in Iran. To find studies published during January 2007 to January 2019, a search strategy was performed by searching different Iranian and international databases, including SID, Google Scholar, Scopus, Medline, Pub Med, and Web of Science.
Findings: The prevalence of vancomycin- and gentamicin-resistant enterococci was very high in Iran (41 and 44%, respectively). Accordingly, Enterococcus faecalis was more prevalent in clinical samples compared to E. faecium (75.49% vs. 24.05%). However, resistance to vancomycin was higher in E. faecium strains compared to E. faecalis.
Conclusion: Due to the increasing vancomycin and gentamicin resistance among Enterococcus species in Iran, it is necessary to design strategies that lead to the rational prescription of antibiotics and limit the spread of resistant enterococci.
Article Type: Systematic Review |
Subject:
Bacteriology
Received: 2021/10/10 | Accepted: 2021/11/19 | Published: 2022/02/21
Received: 2021/10/10 | Accepted: 2021/11/19 | Published: 2022/02/21
Send email to the article author
| Rights and permissions | |
 |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |